APA (7th ed.) Citation

T, M., JI, S., A, A., E, G., A, B., B, E., . . . AF, A. (2026). Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials. American journal of clinical dermatology, 27(1), 149. https://doi.org/10.1007/s40257-025-00985-1

Chicago Style (17th ed.) Citation

T, Mayo, et al. "Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials." American Journal of Clinical Dermatology 27, no. 1 (2026): 149. https://doi.org/10.1007/s40257-025-00985-1.

MLA (9th ed.) Citation

T, Mayo, et al. "Efficacy and Safety of Tralokinumab Across Racial Subgroups in Adults with Moderate-to-Severe Atopic Dermatitis: Post Hoc Analysis of Phase III Trials." American Journal of Clinical Dermatology, vol. 27, no. 1, 2026, p. 149, https://doi.org/10.1007/s40257-025-00985-1.